The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.

The US Food and Drug Administration (FDA) has approved a new treatment for moderate to severe plaque psoriasis.

A promising new drug to help psoriasis patients control their itchy, frustrating outbreaks may soon be on the way.

Like other chronic diseases, psoriasis can cost patients an arm and a leg. And as treatments improve and awareness increases, those treatment costs could be money well spent.

Psoriasis is an inflammatory skin condition, but it may be more than skin-deep. It may also raise high blood pressure risk.

More than 125 million people across the globe have psoriasis. The US Food and Drug Administration (FDA) approved a medicine Tuesday that may be able to treat them.

Psoriasis can be a painful and uncomfortable disease. A few products currently on the market may ease symptoms of this skin condition. Now, a new medication is showing promise in clinical trials.

The health of your heart and that of your skin may not seem that connected, but the authors of a new study suggest that for some women, the two may be intertwined.

About 15 percent of psoriasis patients get arthritic inflammation that may cause joint pain, according to the American College of Rheumatology. A new therapy, however, may bring some relief.

How much harm could a little dry, itchy skin do? This is the attitude with which many people think about psoriasis, not realizing that the skin condition can have far more wide-reaching consequences.